
#479 Managing Treatment-Resistant Depression featuring Dr. Jessi Gold
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Claim CME for this episode at curbsiders.vcuhealth.org!
Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME
Show Segments
- Intro
- Case 1 from Kashlak
- Medical conditions that can mimic depression
- Diagnosis of depression
- How to explain depression to family
- Initial treatment options for depression
- Case 2 from Kashlak
- Suicide risk assessment
- Trialing, augmenting, and tapering of medications
- Pharmacogenetic testing
- Alternate treatment options: TMS, ECT, ketamine, psilocybin, cannabis
- Outro
Credits
- Written and Produced by: Zoya Surani
- Show Notes, Infographic, and Cover Art: Zoya Surani
- Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP
- Reviewer: Sai Achi MD,MBA,FACP
- Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP
- Technical Production: PodPaste
- Guest: Jessi Gold, MD
Disclosures
Dr. Gold reports no relevant financial disclosures. The Curbsiders report no relevant financial disclosures.
Sponsor: Panacea Financial
Visit PanaceaFinancial.com to explore financial solutions designed to make your life better.
Sponsor: FIGS
Go to WearFIGS.com and use the code FIGSRX to get 15% off your first order.
Sponsor: Ezresus
Listeners of the Cribsiders get access to a 2-month free trial, letting them use 100% of the features of the app. For more information visit www.ezresus.com/curbsiders
Sponsor: Freed
Visit Freed.ai and use code CURB50 to get $50 off your first month when you subscribe!
Ce que les auditeurs disent de #479 Managing Treatment-Resistant Depression featuring Dr. Jessi Gold
Moyenne des évaluations de clientsÉvaluations – Cliquez sur les onglets pour changer la source des évaluations.
Il n'y a pas encore de critiques pour ce titre.